NCT03535142View on ClinicalTrials.gov

Prognostic Significance of Fatty Liver Disease in Bariatric Patients

NARecruitingINTERVENTIONAL
Enrollment

1,200

Participants

Timeline

Start Date

August 15, 2018

Primary Completion Date

June 1, 2035

Study Completion Date

April 1, 2038

Conditions
Non-Alcoholic Fatty Liver DiseaseMetabolic EncephalopathyObesity, MorbidNon-alcoholic Steatohepatitis
Interventions
PROCEDURE

Bariatric surgery

Roux en y gastric bypass or gastric sleeve operation

Trial Locations (1)

6700

RECRUITING

Hospital of Southwest Jutland, Esbjerg

All Listed Sponsors
collaborator

University of Southern Denmark

OTHER

collaborator

Odense University Hospital

OTHER

collaborator

Esbjerg University Hospital of South-West Jutland

UNKNOWN

lead

Esbjerg Hospital - University Hospital of Southern Denmark

OTHER